Characteristics Rivaroxaban (n = 6) Warfarin (n = 6) p-value
Age (years), mean ± SD 70.0 ± 17.2 71.8 ± 18.4 0.862
Sex, n (%) Male Female 2 (33) 4 (67) 2 (33) 4 (67)
1
BMI (kg/m2) 25.3 ± 6.0 25.9 ± 5.0 0.866
Smoking, n (%) Yes No 2 (33) 4 (67) 0 (0) 6 (100)
0.455
INR, mean ± SD N/A 2.53 ± 0.27 N/A
TTR (%), mean ± SD N/A 87.00 ± 10.16 N/A
Time on treatment (months), mean 12.7 ± 7.7 N/A N/A
Comorbidities, n (%) Stroke/TIA Ischaemic heart disease Diabetes Hypertension High cholesterol Venous Thromboembolism Chronic kidney disease Chronic liver disease 0 (0) 1 (17) 1 (17) 3 (50) 3 (50) 6 (100) 1 (17) 1 (17) 0 (0) 1 (17 ) 0 (0) 2 (33) 0 (0) 6 (100) 0 (0) 1 (17) 1 1 1 1 0.182 1 1 1
Medication, n (%) Aspirin Statins Ca2+-channel blocker β-blocker Anti-psychotic 0 (0) 3 (50) 1 (17) 1 (17) 1 (17) 0 (0) 0 (0) 0 (0) 1 (17) 1 (17) 1 0.182 1 1 1